• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    56.64 1.04(1.80%) Dec 19, 3:59PM EST
    Add to Portfolio
    Prev Close:57.68
    Open:57.54
    Bid:55.00 x 500
    Ask:59.00 x 200
    1y Target Est:84.89
    Beta:2.4
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:56.42 - 58.71
    52wk Range:35.33 - 93.33
    Volume:1,138,826
    Avg Vol (3m):780,664
    Market Cap:1.92B
    P/E (ttm):N/A
    EPS (ttm):-4.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLVS

    Comparison

    Symbol% ChgMkt Cap
    CLVSDown 1.80%1.92B
    IMMU417.24M
    LRUSFN/A
    THLD192.64M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):143.78
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-4.41
    Quarterly EPS Est (Dec-14) :-1.30
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback